Lindus Health launches Cardiovascular CRO offering.
READ MORE
NEW YORK, NY, September 4, 2024 – Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has introduced its all-encompassing contract research organization (CRO) and technology solution for the execution of ophthalmology clinical trials.
Lindus Health is equipped to execute ophthalmology studies across the US, UK, and Europe. Their “All-in-One Ophthalmology CRO” covers the development of prescription-grade and over-the-counter (OTC) products for an extensive variety of ophthalmic indications, including myopia, macular degeneration, diabetic retinopathy, dry eye, and more.
Ophthalmology clinical trials can generate large volumes of imaging data that necessitate specialized software and expertise for analysis. Due to their frequent requirements for long study participation and long-term follow-up, they often face challenges related to patient retention. Lindus Health’s collaborations with ophthalmologists, optometrists, and primary care physicians (PCPs), combined with its unique approach to end-to-end trial execution, enable ophthalmology sponsors to run highly effective and efficient clinical trials, achieving study milestones twice as fast as traditional CROs.
“We use novel approaches to patient retention and engagement, such as ‘micro-payments’ for completing study activities, personalized outreach and support to participants, and improved patient information and training. This allows us to successfully recruit and execute ophthalmology trials,” said Michael Young, co-founder at Lindus Health. “We’re incredibly excited to debut our one-of-a-kind CRO and technology offering within this market segment.”
The "All-in-One Ophthalmology CRO" offering provides ophthalmology sponsors with an extensive array of features to enhance their clinical research:
“We’ve had a great experience working with Lindus Health,” said Mark Wuttke, CEO at Dopavision. We found them to be proactive, transparent, and they delivered what they said they would on time and on budget. When situations warranted change, they worked with us in the best way to get there.”
Lindus Health is committed to bringing essential and safe therapies for ophthalmic conditions by optimizing all aspects of trial management and execution while ensuring patient-centricity.
To learn more about Lindus Health’s “All-in-One Ophthalmology CRO,” click here.
Lindus Health is an anti-CRO running radically faster and more reliable trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 30 million Electronic Health Records.
Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint by handling the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management.
To date, Lindus Health has delivered clinical trials across the US, UK and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $24M from investors including Peter Thiel, CREANDUM, Firstminute Capital, Seedcamp, Hambro Perks, Amino Collective and Calm/Storm.
Jodi Perkins
Amendola for Lindus Health
jperkins@acmarketingpr.com
Lindus Health Releases "All-in-One Cardiovascular CRO" Offering for Clinical Trials Serving Cardiovascular Health
Introducing our latest CRO offering for the development of cardiovascular interventions.
